World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
119
Citations
77202
World Ranking
570
National Ranking
341

Medicine

D-Index
129
Citations
90582
World Ranking
2529
National Ranking
1425

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Jennifer A. Wargo is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medicine, with significant contributions in oncology, molecular biology, and immunology.

The main fields of study associated with Jennifer A. Wargo include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these areas, notable subfields of research are:

  • Oncology
  • Molecular Biology
  • Immunology
  • Pulmonary and Respiratory Medicine
  • Epidemiology

The topics of work covered show a focus on aspects related to cancer and immune response, with key topics being:

  • Cancer Immunotherapy and Biomarkers
  • Gut Microbiota and Health
  • Immunotherapy and Immune Responses
  • CAR-T Cell Therapy Research
  • Cutaneous Melanoma Detection and Management
  • Cancer Research and Treatments
  • Melanoma and MAPK Pathways

Jennifer A. Wargo has contributed extensively to several publication venues, with the most frequent being:

  • Cancer Research
  • Journal of Clinical Oncology
  • Regular and Young Investigator Award Abstracts
  • Nature
  • Clinical Cancer Research

Their recent published papers include:

  • "B cells and tertiary lymphoid structures promote immunotherapy response," 2020, Nature
  • "Tertiary lymphoid structures improve immunotherapy and survival in melanoma," 2020, Nature
  • "The human tumor microbiome is composed of tumor type-specific intracellular bacteria," 2020, Science
  • "B cells are associated with survival and immunotherapy response in sarcoma," 2020, Nature
  • "Hallmarks of response, resistance, and toxicity to immune checkpoint blockade," 2021, Cell

Frequent collaborators in Jennifer A. Wargo's research include:

  • Nadim J. Ajami
  • Alexander J. Lazar
  • Michael A. Davies
  • Jeffrey E. Gershenwald
  • Elizabeth M. Burton

Best Publications

  • Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

    V. Gopalakrishnan;V. Gopalakrishnan;C. N. Spencer;C. N. Spencer;L. Nezi;A. Reuben

  • Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.

    Padmanee Sharma;Siwen Hu-Lieskovan;Jennifer A. Wargo;Antoni Ribas

  • A landscape of driver mutations in melanoma

    Eran Hodis;Ian R. Watson;Ian R. Watson;Gregory V. Kryukov;Gregory V. Kryukov;Gregory V. Kryukov;Stefan T. Arold

  • B cells and tertiary lymphoid structures promote immunotherapy response

    Beth A. Helmink;Sangeetha M. Reddy;Jianjun Gao;Shaojun Zhang

  • Tertiary lymphoid structures improve immunotherapy and survival in melanoma.

    Rita Cabrita;Martin Lauss;Adriana Sanna;Marco Donia

  • Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

    Ravid Straussman;Teppei Morikawa;Kevin Shee;Michal Barzily-Rokni

  • B cells are associated with survival and immunotherapy response in sarcoma.

    Florent Petitprez;Aurélien de Reyniès;Emily Z. Keung;Tom Wei Wu Chen

  • Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.

    Leore T. Geller;Michal Barzily-Rokni;Tal Danino;Oliver H. Jonas;Oliver H. Jonas

  • COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

    Cory M Johannessen;Jesse S. Boehm;So Young Kim;Sapana R. Thomas;Sapana R. Thomas

  • RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)

    Poulikos I. Poulikakos;Yogindra Persaud;Manickam Janakiraman;Xiangju Kong

  • Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy

    Weiyi Peng;Jie Qing Chen;Chengwen Liu;Shruti Malu

  • The human tumor microbiome is composed of tumor type–specific intracellular bacteria

    Deborah Nejman;Ilana Livyatan;Garold Fuks;Nancy Gavert

  • Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.

    Moshe Sade-Feldman;Moshe Sade-Feldman;Keren Yizhak;Stacey L. Bjorgaard;Stacey L. Bjorgaard;John P. Ray

  • Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes

    Erick Riquelme;Erick Riquelme;Yu Zhang;Liangliang Zhang;Maria Montiel

  • Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

    Erez N. Baruch;Erez N. Baruch;Ilan Youngster;Guy Ben-Betzalel;Rona Ortenberg

  • Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy

    Jianjun Gao;Lewis Zhichang Shi;Hao Zhao;Jianfeng Chen

  • Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade

    Spencer C. Wei;Jacob H. Levine;Alexandria P. Cogdill;Yang Zhao

  • The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy

    Vancheswaran Gopalakrishnan;Beth A. Helmink;Christine N. Spencer;Alexandre Reuben

  • EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib

    Ryan B. Corcoran;Hiromichi Ebi;Alexa B. Turke;Erin M. Coffee

  • Pancreatic ductal adenocarcinoma: Long-term survival does not equal cure

    Cristina R. Ferrone;Rafael Pieretti-Vanmarcke;Jordan P. Bloom;Hui Zheng

Frequent Co-Authors

Michael A. Davies
Michael A. Davies The University of Texas MD Anderson Cancer Center
Keith T. Flaherty
Keith T. Flaherty Harvard University
Patrick Hwu
Patrick Hwu The University of Texas MD Anderson Cancer Center
Jeffrey E. Gershenwald
Jeffrey E. Gershenwald The University of Texas MD Anderson Cancer Center
Dennie T. Frederick
Dennie T. Frederick Broad Institute
Alexander J. Lazar
Alexander J. Lazar The University of Texas MD Anderson Cancer Center
Padmanee Sharma
Padmanee Sharma The University of Texas MD Anderson Cancer Center
James P. Allison
James P. Allison The University of Texas MD Anderson Cancer Center
Adi Diab
Adi Diab The University of Texas MD Anderson Cancer Center
Chantale Bernatchez
Chantale Bernatchez The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare careers or flexible education paths can expand your opportunities beyond traditional medical degrees. Many students today opt for nursing schools that don't require teas or hesi exams, reducing admission barriers and streamlining the journey into nursing.

For those eager to enter healthcare management quickly, pursuing an accelerated healthcare administration degree is a popular choice. This online pathway allows you to build leadership skills and step into healthcare administration roles sooner.

Registered nurses who wish to advance their practice may consider specialized bridge programs. The adn to fnp route enables RNs with an associate degree to earn a Master’s and become Family Nurse Practitioners in less time.

If nutrition and wellness are of interest, an online nutrition degree offers the flexibility to study remotely while preparing for roles in dietetics, education, or public health.

Best Scientists Citing Jennifer A. Wargo

Trending Scientists